OBJECTIVE
To characterise the skeletal muscle changes in the neuroleptic malignant syndrome (NMS).
METHODS
Detailed light and ultrastructural examination was carried out on skeletal muscle from three cases of NMS, two associated with recreational drugs (3,4-methlenedioxymethylamphetamine (MDMA,